The Latest
-
ResMed quarterly revenue beats estimates as supply chain woes ease
Demand for CPAP devices and respirators remains strong as the company expects to pick up additional market share from rival Philips, and demand grows for its medical SaaS products.
-
Medtronic wearable partner files for bankruptcy but plans to continue ‘without interruption’
Rockley Photonics works with two of the top five medtech companies, plus six leading smart watch makers including Apple, but has run into financial problems.
-
LivaNova recalls circulatory support device for software fix
The update is intended to fix a malfunction that could cause its LifeSPARC pump to stop working.
-
Medtech trends in 2023
Medtech regulation outlook in 2023: Faster approvals among priorities as AI moves to fore
Leaders in the medtech field weigh in on the prospects and challenges for product regulation in 2023.
Updated Jan. 26, 2023 -
Opinion
Why medical device designers need to become more agile — and how they can do it
To stay competitive, medtech firms must center manufacturing in business optimization plans, while embracing a design-to-value approach, says Jennifer Samproni, Flex’s chief technology officer for its Health Solutions division.
-
Researchers create remote-controlled biological robot that could eventually be used in surgery
The design allows the integration of sensors and other components that could eventually equip the robots to detect biomarkers of disease, carry out biopsies or perform surgery.
-
Getinge heart pump gets third Class I recall after patient death
Customers were alerted to problems with Cardiosave devices late last year after Getinge received complaints about an issue linked to four serious injuries and one death.
-
Cybersecurity ‘more critical than ever’ in era of connected care: BD
The device maker’s annual report on the state of healthcare cybersecurity calls for better transparency and coordination across the industry.
-
Abbott sees ‘signs of stability’ for 2023 as hospital staffing, supply chain improves
While the company continues to grapple with supply shortages and procedure restrictions, it sold more COVID-19 tests than expected in the fourth quarter.
-
Intuitive Q4 profit slips on costs to boost share of robotic surgery market
The investment in innovation comes as Intuitive tries to maintain its dominant position in the face of rivals including Johnson & Johnson and Medtronic.
-
3M’s healthcare unit Q4 earnings drop on nurse shortages, falling hospital budgets
Elective healthcare procedure volumes were about 90% of pre-COVID levels.
-
Insulet reports personal-data leak of 29,000 insulin pump customers
In a recall communication to users, Insulet shared information with its website performance and marketing partners through cookies and other trackers embedded in its website.
-
J&J sees Abiomed adding to revenue in 2024; Q4 sales drop
Foreign-exchange fluctuations helped curb revenue in the period.
-
Q&A
3 questions for Michael Snyder, lead inventor of single-drop blood test
The head of a Stanford research team says the test differs from Theranos' defunct product because "ours works."
-
Deep Dive // Medtech trends in 2023
Diabetes outlook: What Dexcom, Medtronic and other leaders are watching in 2023
From new product launches to regulatory changes that could expand CGM coverage, company executives and analysts share their predictions.
-
EPA. (2022). "https://www.epa.gov/hazardous-air-pollutants-ethylene-oxide/forms/columbus-nebraska-becton-dickinson-pharmaceutical" [Photo]. Retrieved from EPA.gov.
Ethylene oxide regulation may disrupt device supply, AdvaMed warns White House
The trade group has asked President Joe Biden to consider the potential threat to patient care if facilities are shut down.
-
Courtesy of https://news.medtronic.com/Left-Ventricular-Assist-Device-For-Advanced-Heart-Failure#assets_34137_10-122:19299
Medtronic asks HVAD users to return batteries with welding defects
The recall is one of several related to battery issues after the heart pump was pulled from the market.
-
Stanford team reports progress with Theranos-like finger prick blood test
The researchers have created a system for capturing and analyzing thousands of molecules from a single drop of blood.
-
Q&A
Dexcom CEO discusses 2023 plans, expanding to more patients with Type 2 diabetes
MedTech Dive caught up with Kevin Sayer for a conversation about forthcoming product launches and long-term plans to expand CGMs to a broader group of patients.
Updated Jan. 20, 2023 -
FDA demands additional data on Abbott rival to Medtronic balloon, setting back approval timeline
Abbott’s partner Surmodics is “evaluating options” to reduce its spending while preparing a response to the regulator’s requests.
-
Medtech hazards: Problems with Philips’ recall put safety of home-use devices at top of danger list
Patient safety group ECRI is challenging manufacturers to provide easy-to-follow device registration instructions and write simply worded recall notices.
-
Opinion
Realizing the promise of AI for medical imaging and diagnosis
Alissa Hsu Lynch, global lead for MedTech Strategy & Solutions at Google Cloud, explains how medtech companies can benefit from applying AI to the explosion of medical imaging data.
-
CT scans offer new path to diagnose treatable cause of high blood pressure, study shows
While the approach could increase demand for CT imaging, the supply of radioactive tracers is potentially a barrier to adoption of the technique.
-
Deep learning may improve triaging of people with acute chest pain, study shows
The researchers trained a model to find signs in scans that a person may have a serious cardiovascular condition.
-
Abbott’s FDA approval for TAVI device tees up challenge to Edwards, Medtronic: analysts
Abbott has captured about 9% of the European market and aims to become a “credible third player” in the U.S.